Companies · Healthtech

Neosync IncSummer 2022Acquired

SOUTH BOSTON · CA, USA · Healthtech · refined from filed group “Other · founded 2022 · https://neosync.dev

Diligence memoA one-page analyst read on Neosync Inc — recommendation, valuation, rhythm, risks.
$12.4M
Total raised · real
2
Rounds
2.6×
Latest step-up
Top 28%
Sector rank · raised
Series A
Latest stage · inferred · Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time)

Neosync Inc looks over-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the healthtech sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Over-valued
  • Modeled value is 1.52× the median modeled value of Series A Healthtech companies in 2016–2018 (103 peers) — value vs value, same stage and era.
Dormant
  • Last raise 9.0 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Healthtech

Neosync Inc is one of 2138 Healthtech companies tracked from SOUTH BOSTON, CA, USA, on record since 2022. By capital raised it ranks in the upper tier (ahead of 73% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

AI analyst read est. — model-extracted from this company's public description, not a verified fact. 30%

operates a technology-led product inferred from public copy

Grounded in: “You are a venture analyst

Neosync is an open-source anonymization and synthetic data platform.

Neosync is an open-source platform that allows you to create anonymized or synthetic data and sync it across all environments for testing and machine learning. Companies in highly regulated industries such as FinTech, HealthTech, InsureTech and those with sensitive data can use Neosync to create production-like data to use for debugging and building features in lower-level environments without the security and privacy risk of using production data.

B2BDeveloper ToolsSaaSai/mldata/analyticsfintechhealthtech
Find Neosync Inc online

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
4
Investors (latest)
2017-06-13
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$125M$250M$375M$500MSeed · 2010-06-09 Raised $3.4M (real) Modeled valuation $95M (est)$3.4M$95MSeed2010Series A · 2017-06-13 Raised $9.0M (real) Modeled valuation $203M (est)$9.0M$203MSeries A2017+$9.0MCumulative $12M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Seed$3.4M · 2010
Series A$9.0M · 2017

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 67%.

Modeled valuation trajectory
$203.2M
Base estimate est.
$11.5M
Conservative case
$1.1B
Upside case
$40.9M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the healthtech sector profile. Directional, not a quoted figure.

Seed · modeled $94.6M · 2010-06-092010Series A · modeled $203.2M · 2017-06-132017
Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
52%
Survival probability
28% low · 71% high
1.46×/yr
Annual markup
1.84×/yr upside case
6.0 yr
Elapsed time used
9.1 yr actual, capped for stale marks
healthtech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
84 mo
Avg between rounds
$1.8M/yr
Capital velocity
16.1 yr
On record since
2010
First round
2
Rounds on file
How it compares to the market

Benchmarked against 2138 companies in Healthtech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 2.8× above median
This company$12.4M
Sector median$4.5M
Latest round — vs other Series A rounds in sector (real $, this stage) 1.6× above median
This company$9.0M
Sector median$5.5M
Modeled value — vs sector median (estimate, all stages) 6.0× above median
This company$203.2M
Sector median$33.8M

Raised more than 73% of sector peers (real $). Modeled value above 86% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #28 of 103.

This companyCohort peer
$100.0M$1.0B$10.0M$100.0MCapital raised (log)HealthMyne, Inc. · Series A Raised $21.9M · modeled $338.6M (est)Prenexus Health, LLC · Series A Raised $30.0M · modeled $338.6M (est)Companion Medical, Inc. · Series A Raised $20.5M · modeled $318.6M (est)Health at Scale Corp · Series A Raised $14.0M · modeled $316.0M (est)Motus GI Medical Technologies, Ltd. · Series A Raised $13.8M · modeled $310.8M (est)Cohero Health, Inc. · Series A Raised $13.3M · modeled $301.3M (est)Apama Medical, Inc. · Series A Raised $14.3M · modeled $297.4M (est)Parsley Health, Inc. · Series A Raised $14.5M · modeled $289.1M (est)Trilliant Health, Inc. · Series A Raised $12.7M · modeled $285.9M (est)Dental Whale, LLC · Series A Raised $12.5M · modeled $282.2M (est)Praestan Health Llc · Series A Raised $12.0M · modeled $270.9M (est)Livestock Health Solutions, LLC · Series A Raised $12.0M · modeled $270.9M (est)Neosync Inc (this company) Raised $12.4M · modeled $203.2M (est)Neosync Inc
CompanyStageRaised · realValue · estvs peer med.
HealthMyne, Inc.Series A$21.9M$338.6M2.53×
Prenexus Health, LLCSeries A$30.0M$338.6M2.53×
Companion Medical, Inc.Series A$20.5M$318.6M2.38×
Health at Scale CorpSeries A$14.0M$316.0M2.36×
Motus GI Medical Technologies, Ltd.Series A$13.8M$310.8M2.33×
Cohero Health, Inc.Series A$13.3M$301.3M2.25×
Apama Medical, Inc.Series A$14.3M$297.4M2.23×
Parsley Health, Inc.Series A$14.5M$289.1M2.16×
Trilliant Health, Inc.Series A$12.7M$285.9M2.14×
Dental Whale, LLCSeries A$12.5M$282.2M2.11×
Praestan Health LlcSeries A$12.0M$270.9M2.03×
Livestock Health Solutions, LLCSeries A$12.0M$270.9M2.03×
Neosync Inc this companySeries A$12.4M$203.2M1.52×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Seed$3.4M2010-06-09$17.1M$94.6M85%
Series A$9.0M2017-06-13$40.9M$203.2M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Seed$3.4M2010-06-09
    • First recorded raise — entered as Seed.
    • 7 investors on this round.
  2. Series A$9.0M2017-06-13
    • Raised again after 84 mo — slower than the ~14 mo sector norm.
    • Round 2.6× larger than the prior — scaling up.
    • Switched to Rule 506(b) (was Rule 06).
    • 4 investors on this round.
Intelligence
2024 ~Q2
Modeled next raise · ~84mo cadence
$23.8M
Modeled next size est.range $15.4M$38.0M
2.6×
Last step-up
$1.8M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Lawrence C. Best3 other2010-06
James William Phillips2010-06
Jan C. Pensaert2017-06
Kathryn Rumrill2017-06
Sacha C. Lainovic2010-06
Yi William Jin2010-06
Registry & provenance

Neosync Inc is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1428460
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Insightin Health IncHealthtechSeries A$12.4M$234.4Msame sector · same stage
Dental Whale, LLCHealthtechSeries A$12.5M$282.2Msame sector · same stage
O.J. Medtech Holdings, LLCHealthtechSeries A$12.5M$161.4Msame sector · same stage
Blue Ox Healthcare Partners SP, LLCHealthtechSeries A$12.6M$284.7Msame sector · same stage
Trilliant Health, Inc.HealthtechSeries A$12.7M$285.9Msame sector · same stage
Health Warrior, Inc.HealthtechSeries A$12.7M$112.9Msame sector · same stage
Fresenius Medical Care Baldwin County, LLCHealthtechSeries A$12.8M$289.6Msame sector · same stage
Livestock Health Solutions, LLCHealthtechSeries A$12.0M$270.9Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Neodocs
Instant lab tests on your smartphone
AI / ML74%
BioStack Platforms
Real world training envs for healthcare AI models
Pharma72%
Neo on Business Ltd.Other TechnologySeries A$265.5M71%
Ruta Health
Async personalized and actionable health education by real doctors
Healthtech71%
Latent
Medical language models to automate healthcare operations
Healthtech70%
Syntra
Medical chart intelligence
Healthtech70%
FutureClinic
Personal doctors through chat
Healthtech70%
Neograft Technologies, Inc.Software / TechSeries A$138.7M70%
Frequently asked
How much funding has Neosync Inc raised?
Neosync Inc has raised approximately $12.4M in disclosed capital across 2 recorded financing rounds, aggregated from public filings.
What is Neosync Inc's estimated valuation?
Provath's modeled valuation for Neosync Inc is approximately $203.2M (modeled range $11.5M–$1.1B). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Neosync Inc at?
Neosync Inc's latest modeled financing stage is Series A. Its most recent recorded round closed around Tue Jun 13.
What does Neosync Inc do and where is it based?
Neosync Inc operates in the Healthtech sector, based in SOUTH BOSTON, CA, USA. Neosync is an open-source anonymization and synthetic data platform.
Explore related

See where Neosync Inc sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Neosync Inc, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.